Search

everythinglearnresearchcommunity

for

Search:↓

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Women with PCOS have a higher risk of heart disease.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Different progestins work similarly for contraception but have unique effects suited to individual needs.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

New treatments aim to improve thin endometrium to help more couples with infertility.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Acyzol could help treat conditions caused by zinc deficiency.